Anticoagulant Reversal Drugs Market Size Is Projected to Reach $2.20 Billion By 2028 | CAGR: 14.4%: Polaris Market Research

News provided by

Sep 07, 2021, 08:52 ET

NEW YORK, Sept. 7, 2021 /PRNewswire/ -- The global anticoagulant reversal drugs market size is expected to reach USD 2.20 billion by 2028 according to a new study conducted by Polaris Market Research. The market is anticipated to register a CAGR: 14.4%. The increasing prevalence of the bleeding disorder, a growing number of clinical trials conducted, and the rise in patient rate undergoing anticoagulant therapy are some of the primary factors propelling the market growth. Additionally, the availability of a strong distribution channel, increasing investment from market players, and expanding product pipeline are further drives the overall growth of the market. Moreover, the rise in R&D activities for the development of novel therapeutics and quicker approval for new drugs are making a positive impact on the market.

Request For a Sample Report: https://www.polarismarketresearch.com/industry-analysis/anticoagulant-reversal-drugs-market/request-for-sample

Key Highlights of Anticoagulant Reversal Drugs Market

Based on product, the idarucizumab segment accounted for the largest share in the anticoagulant reversal drugs market. Rapid approval for a product in several leading countries owing to its high potential is turning out as a major booster for this segment's growth.
In terms of distribution channel, the hospital pharmacy segment dominated the market and is expected to perform better during the forecast period. The segment's growth is attributed to an increasing number of private hospital chains supported by favorable government policies.
The COVID-19 outbreak had a positive impact on the anticoagulant reversal drugs market on account of the association of COVID-19 infection with blood disorders. Additionally, there is a surge in demand for anticoagulant reversal drugs due to increasing anticoagulants boosting the market growth.

Regional Developments

North America is holding its dominant position in the global anticoagulant reversal drugs market and is anticipated to make this position more firm during the forecast period. A rise in drug approvals from USFDA and increasing initiatives to contain the cases of blood disorder are working in the favor of this regional market. On the other side, Asia Pacific is expected to witness substantial growth, owing to the rise in the incidence of bleeding disorders and increasing health awareness among the population.

Request for Discount Pricing At : https://www.polarismarketresearch.com/industry-analysis/anticoagulant-reversal-drugs-market/request-for-discount-pricing

Competitive Outlook

Leading market participants are involved in several key tactics such as awareness programs, new product launches, and collaborations with other market players. In addition to this, several new entrants are finding the market with lucrative opportunities and investing for their expansion across regions. Some of the prominent market players are Portola Pharmaceuticals, CSL Behring, Bausch Health Companies Inc., Alps Pharmaceutical Ind. Co., Ltd, Boehringer Ingelheim, Octapharma AG, AMAG Pharmaceuticals, Inc., Pfizer, Inc., Dr. Reddy's Laboratories, SG Pharma Pvt Ltd., and Fresenius Kabi AG.

Target Audience

Supply Side: Pharmaceutical Company
Demand Side: Hospital, Retail and Online Pharmacy
Regulatory Side: World Health Organization

Have Any Query Or Specific Requirement? Feel Free To Ask Our Industry Experts At : https://www.polarismarketresearch.com/industry-analysis/anticoagulant-reversal-drugs-market/speak-to-analyst

Polaris Market Research has segmented the anticoagulant reversal drugs market report on the basis of product, distribution channel and region:

Anticoagulant Reversal Drugs, Product Outlook (Revenue – USD Million, 2016 – 2028)

Prothrombin Complex Concentrates
Phytonadione
Andexanet Alfa
Idarucizumab
Protamine
Others

Anticoagulant Reversal Drugs, Distribution Channel Outlook (Revenue – USD Million, 2016 – 2028)

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Anticoagulant Reversal Drugs, by Regional Outlook (Revenue – USD Million, 2016 – 2028)

North America

U.S.
Canada

Europe

France
Germany
UK
Italy
Spain
Netherlands
Austria

Asia Pacific

China
India
Japan
Malaysia
South Korea
Indonesia

Central & South America

Mexico
Brazil
Argentina

Middle East & Africa

UAE
Saudi Arabia
Israel
South Africa

Find more research reports on Healthcare by PMR

Complementary and Alternative Medicine Market Share, Size, Trends, Industry Analysis Report, By Intervention (Traditional Alternative Medicine/Botanicals, Mind Healing, Body Healing, External Energy, Sensory Healing), By Distribution Method, By Region; Segment Forecast, 2021 – 2028

Pharmacy Automation Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Medication Dispensing Systems, Packaging & Labeling Systems, Storage & Retrieval Systems, Automated Medication Compounding Systems, Tabletop Tablet Counters); By Application; By Regions; Segment Forecast, 2021 – 2028

Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow (Discovery Informatics, Development Informatics); By Mode (Outsourced, In-house); By Services (Sequence Analysis Platforms, Molecular Modeling, Docking, Clinical Trial Data Management, Others); By Regions; Segment Forecast, 2021 – 2028

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:
Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-917-985-9017
Email: [email protected]
Web: https://www.polarismarketresearch.com/
Follow US: LinkedIn | twitter